zidovudine has been researched along with thiophenes in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chavan, SJ; Prochaska, HJ | 1 |
Baron, P; Polsky, B; Prochaska, HJ; Yeh, Y | 1 |
Erlichman, C; Pressacco, J | 1 |
Klarmann, GJ; North, TW; Preston, BD; Schinazi, RF; Smith, RA | 1 |
Feuston, B; Getty, K; Hazuda, DJ; Krueger, J; Lewis, D; Miller, MD; Munshi, V; Parniak, MA; Shaw-Reid, CA | 1 |
5 other study(ies) available for zidovudine and thiophenes
Article | Year |
---|---|
Fluorometric measurement of reverse transcriptase activity with 4',6-diamidino-2-phenylindole.
Topics: Antiviral Agents; Dideoxynucleotides; Fluorescent Dyes; HIV Reverse Transcriptase; HIV-1; Indicators and Reagents; Indoles; Kinetics; Nevirapine; Phosphorus Radioisotopes; Pyrazines; Pyridines; Radioisotope Dilution Technique; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spectrometry, Fluorescence; Thiones; Thiophenes; Thymine Nucleotides; Zidovudine | 1995 |
Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Glutathione; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphoma, T-Cell, Cutaneous; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Pyrazines; Reverse Transcriptase Inhibitors; Skin Neoplasms; Thiones; Thiophenes; Time Factors; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1993 |
Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
Topics: Colony-Forming Units Assay; DNA Damage; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Hematopoietic Stem Cells; Humans; Quinazolines; Thiophenes; Thymidylate Synthase; Tritium; Tumor Cells, Cultured; Zidovudine | 1993 |
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
Topics: Catalytic Domain; Cytidine Triphosphate; Dideoxynucleotides; Dose-Response Relationship, Drug; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Lamivudine; Mutation; Proline; Reverse Transcriptase Inhibitors; Thionucleosides; Thiophenes; Thymine Nucleotides; Transcription, Genetic; Zalcitabine; Zidovudine | 2000 |
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Topics: Anti-HIV Agents; Binding Sites; Butyrates; Catalysis; Dideoxynucleotides; DNA-Directed DNA Polymerase; Drug Combinations; Drug Synergism; Foscarnet; HIV Reverse Transcriptase; Hydrolysis; Kinetics; Nucleic Acid Synthesis Inhibitors; Oxazines; Reverse Transcriptase Inhibitors; Ribonuclease H; Thiophenes; Thymine Nucleotides; Zidovudine | 2005 |